|
| Exchange Disseminated Time 06/02/2017 15:48:32 | Marksans Pharma Ltd has announced the following results for the quarter ended December 31, 2016:
The Unaudited Standalone results for the Quarter ended December 31, 2016
The Company has posted a net profit of Rs. 84.39 million for the quarter ended December 31, 2016 as compared to Rs. 139.88 million for the quarter ended December 31, 2015. Total Income has decreased from Rs. 692.95 million for the quarter ended December 31, 2015 to Rs. 645.81 million for the quarter ended December 31, 2016.
The Consolidated Results are as follows:
The Unaudited Consolidated results for the Quarter ended December 31, 2016
The Group has posted a net profit after taxes, minority interest and share of profit of associates of Rs. 113.03 million for the quarter ended December 31, 2016 as compared to Rs. 179.34 million for the quarter ended December 31, 2015. Total Income has decreased from Rs. 2175.11 million for the quarter ended December 31, 2015 to Rs. 2152.48 million for the quarter ended December 31, 2016. |
|
|